- Canbridge Pharmaceuticals reported resignation of joint company secretary Wai Chiu Wong, effective March 30, 2026.
- Wong also stepped down as authorized representative, effective March 30, 2026.
- Qian Ma, existing joint company secretary, was appointed authorized representative, effective March 30, 2026.
- Lin Sio Ngo was named process agent, effective March 30, 2026.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Canbridge Pharmaceuticals Inc. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260331-12080805), on March 30, 2026, and is solely responsible for the information contained therein.
Comments